AbbVie Inc. (ABBV) vs Novo Nordisk A/S (NVO)
A side-by-side comparison of AbbVie Inc. and Novo Nordisk A/S across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.
ABBV
AbbVie Inc.
$250.88HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT
NVO
Novo Nordisk A/S
$47.08HealthcareDelayed quote: Jul 31, 2026, 3:59 PM EDT
Total return — ABBV vs NVO
growth of $100 · dividends reinvested · last 14yABBV +1141.9%NVO +292.9%ABBV compounded faster
ABBV NVO
ABBV vs NVO: by the numbers
- •ABBV is the larger company ($443.24B vs $209.19B market cap).
- •NVO trades at the lower trailing earnings multiple (11.01 vs 126.22 P/E), one valuation lens rather than an overall verdict.
- •NVO converts more revenue to profit (37.14% vs 5.79% net margin).
- •NVO grew revenue faster over the past five years (20.73% vs 4.59% CAGR).
- •NVO pays the higher dividend yield (3.83% vs 2.62%).
Metrics side by side
Valuation
| Metric | ABBV | NVO |
|---|---|---|
| P/E ratio | 126.22 | 11.01 |
| P/S ratio | 7.27 | 4.09 |
| P/B ratio | N/A | 6.69 |
| PEG ratio | N/A | 8.16 |
| EV / EBITDA | 20.50 | 8.62 |
| FCF yield | 4.57% | 2.31% |
Profitability
| Metric | ABBV | NVO |
|---|---|---|
| Gross margin | 70.68% | 81.83% |
| Operating margin | 27.60% | 45.21% |
| Net margin | 5.79% | 37.14% |
| ROE | -129.24% | 60.74% |
| ROIC | 12.97% | 29.53% |
Dividends
| Metric | ABBV | NVO |
|---|---|---|
| Dividend yield | 2.62% | 3.83% |
| Payout ratio | 284.39% | 49.80% |
Growth (annualized)
| Metric | ABBV | NVO |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 20.73% |
| EPS CAGR (5Y) | -2.79% | 19.59% |
| FCF CAGR (5Y) | 3.24% | -5.86% |
| Total return CAGR (5Y) | 21.13% | 2.46% |
Frequently asked
- Which has the lower trailing P/E, ABBV or NVO?
- NVO has the lower trailing P/E: ABBV trades at 126.22 and NVO at 11.01. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or NVO?
- Over the past five years, NVO grew revenue faster — ABBV at a 4.59% CAGR versus NVO at 20.73%.
- Does ABBV or NVO pay a bigger dividend?
- ABBV yields 2.62% and NVO yields 3.83% based on trailing dividends and the latest price.
- Is ABBV or NVO more profitable?
- NVO runs the higher net margin — ABBV at 5.79% versus NVO at 37.14%.
- How have ABBV and NVO total returns compared?
- Over the past 10 years, ABBV delivered 19.10% and NVO delivered 7.59% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioNovo Nordisk A/S P/E ratioAbbVie dividend yieldNovo Nordisk A/S dividend yieldAbbVie ROENovo Nordisk A/S ROEAbbVie operating marginNovo Nordisk A/S operating marginAbbVie revenue growthNovo Nordisk A/S revenue growthAbbVie free cash flowNovo Nordisk A/S free cash flow
AbbVie & Novo Nordisk A/S appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.